A von Stackelberg
Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008(2009)335 cited
- → The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse(2014)119 cited
- → Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation(2015)81 cited
- → Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report(2011)79 cited
- → High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse(2011)75 cited
- → Anti–Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials(2011)62 cited
- → CHILDHOOD ALL BLASTS RETAIN PHENOTYPIC AND GENOTYPIC CHARACTERISTICS UPON LONG-TERM SERIAL PASSAGE IN NOD/SCID MICE(2000)50 cited
- → Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia(2016)37 cited
- → ALL-REZ BFM - The Consecutive Trials for Children with Relapsed Acute Lymphoblastic Leukemia(2013)28 cited
- Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.(2006)